Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)

NCT02928497 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT02928497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02928497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Terminated
Start date
February 6, 2017
Completion date
September 23, 2025
Enrollment
481 (actual)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

stroke